Showing results (291-300 of 328) with videos related to

Sort By:
Pageof 33
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 22, 2023
Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ)Susanna Naggie, Aaron Milstone, Mario Castro, et al.
American Heart Journal|May 22, 2022
The trial to assess chelation therapy 2 (TACT2): Rationale and designGervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
Journal of Clinical and Translational Science|October 31, 2024
ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemicMaryam Keshtkar-Jahromi, Kevin J Anstrom, Christina Barkauskas, et al.
The New England Journal of Medicine|November 10, 2015
Isosorbide Mononitrate in Heart Failure with Preserved Ejection FractionMargaret M Redfield, Kevin J Anstrom, James A Levine, et al.
JAMA|June 24, 2005
Staphylococcus aureus endocarditis: a consequence of medical progressVance G Fowler, Jose M Miro, Bruno Hoen, et al.
JAMA Internal Medicine|March 3, 2025
Multivitamins After Myocardial Infarction in Patients With Diabetes: A Randomized Clinical TrialFrancisco Ujueta, Gervasio A Lamas, Kevin J Anstrom, et al.
European Journal of Heart Failure|February 16, 2025
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trialClara I Saldarriaga, Faiez Zannad, Ciaran J McMullan, et al.
European Journal of Heart Failure|October 30, 2024
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trialYogesh N V Reddy, Javed Butler, Kevin J Anstrom, et al.
JAMA|November 6, 2007
Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarctionJames G Jollis, Mayme L Roettig, Akinyele O Aluko, et al.
Pageof 33